CPH 0.00% 0.9¢ creso pharma limited

no, director payments almost doubled over the last quarter to...

  1. 4,251 Posts.
    lightbulb Created with Sketch. 684
    no, director payments almost doubled over the last quarter to reach nearly $680, but they did decline in percentage terms.

    bigger issues are the Mernova revenues, or lack thereof. Something has gone awry there and the market has not been kept informed IMHO...
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.